ZONISAMIDE
Generic: ZONISAMIDE
Sun Pharmaceutical IndustriesManufacturer
ORALRoute
ZONISAMIDEActive Substance
2006-03-17Original Approval
ZONISAMIDE is FDA application ANDA077634, sponsored by SUN PHARM INDS (IN). Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2021-08-27
Zonisamide Capsules USP 50 mg 100 Capsules Rx Only NDC 68462-129-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA CGMP Deviations
Class II2022-04-25
Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals, Inc.cGMP deviations
Class II2022-04-25
Zonisamide Capsules USP, 25 mg, packaged in 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals, Inc.,cGMP deviations
Class II2021-08-27
Zonisamide Capsules USP 100 mg Rx Only Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 ManufacturedCGMP Deviations
Class II2022-04-25
Zonisamide Capsules, USP, 100 mg, packaged in: a) 100-count bottle (NDC 68462-130-01); b) 500-count bottle (NDC 68462-13cGMP deviations
Top Reported Reactions
1
DRUG INEFFECTIVE
1,388 reports
2
SEIZURE
1,206 reports
3
OFF LABEL USE
810 reports
4
FATIGUE
500 reports
5
SOMNOLENCE
475 reports
6
DIZZINESS
402 reports
7
NAUSEA
387 reports
8
FALL
369 reports
9
HEADACHE
364 reports
10
CONDITION AGGRAVATED
360 reports